ERBB2 and ovarian cancer: These new high throughput testing methodologies, can detect multiple ovarian cancer biomarkers including focal amplifications of the HER2 and CCNE1 oncogenes, and somatic deletions of the BRCA1, BRCA2 genes in a single test.